论文部分内容阅读
目的:探讨分析尿微量白蛋白与尿糖联合检测在糖尿病早期肾损伤诊断中的临床价值。方法:随机选取2015年11月~2016年7月我院71例糖尿病患者作为研究组,另选同期健康体检者71例作为对照组,均接受尿糖、尿微量白蛋白检测。结果:研究组尿微量白蛋白水平为(29.53±2.18)mg/L、尿糖值为(3.02±0.44)mmol/L,均明显高于对照组(10.17±1.92)mg/L、(1.75±0.38)mmol/L,差异有统计学意义(p<0.05);研究组联合检测尿微量白蛋白、尿糖的阳性率显著高于单一检测阳性率(p<0.05)。结论:联合检测尿微量白蛋白和尿糖能够有效提高糖尿病早期肾损伤的检出率,降低漏诊、误诊率,具有良好的诊断价值。
Objective: To investigate the clinical value of urine microalbumin and urine sugar in the diagnosis of early diabetic nephropathy. Methods: A total of 71 diabetic patients in our hospital from November 2015 to July 2016 were selected as the research group, and 71 healthy subjects were selected as the control group during the same period. Urine and urine microalbumin were detected. Results: Urine microalbuminuria in the study group was (29.53 ± 2.18) mg / L and urine glucose was (3.02 ± 0.44) mmol / L, which were significantly higher than those in the control group (10.17 ± 1.92) mg / L and 0.38) mmol / L, the difference was statistically significant (p <0.05). The positive rate of urine microalbuminuria and urine glucose in the study group was significantly higher than that of single test (p <0.05). Conclusion: The combined detection of urinary albumin and urine sugar can effectively improve the detection rate of early diabetic kidney injury, reduce the missed diagnosis and misdiagnosis rate, and has a good diagnostic value.